Stay updated with breaking news from Nasdaq Nerv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Minerva Neurosciences, Inc. (NASDAQ:NERV – Free Report) – Stock analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for Minerva Neurosciences in a research note issued on Friday, February 23rd. HC Wainwright analyst D. Tsao anticipates that the biopharmaceutical company will post earnings per share of $0.90 for the year. HC Wainwright […]
StockNews.com upgraded shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) from a sell rating to a hold rating in a report published on Thursday. Minerva Neurosciences Stock Up 5.6 % Minerva Neurosciences stock traded up $0.43 during mid-day trading on Thursday, hitting $8.14. The company had a trading volume of 15,523 shares, compared to its […]
Minerva Neurosciences, Inc. (NASDAQ:NERV – Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 49,000 shares, a drop of 16.9% from the September 30th total of 59,000 shares. Approximately 1.0% of the shares of the stock are sold short. Based […]
StockNews.com upgraded shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright upped their price objective on shares of Minerva Neurosciences from $8.00 to $11.00 and gave the company a neutral rating in a report on Wednesday, August 2nd. […]
StockNews.com upgraded shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright boosted their price target on shares of Minerva Neurosciences from $8.00 to $11.00 and gave the company a neutral rating in a report on Wednesday, August 2nd. […]